Radiology Business May 17, 2024
Amid “ever-escalating” costs in cancer care for patients, experts believe it’s becoming “imperative” that radiologists and radiation oncologists help screen for signs of financial toxicity, according to new research published Thursday.
However, despite this dire need, there is wide variability in such processes, including the timing, setting, tools utilized and interpretation of the results. Researchers are calling for more uniformity in this space during a time when payers are increasingly shifting costs to patients in the form of premiums, deductibles and copayments.
“There is a wide gap in integrating routine assessment and management of [financial toxicity] in cancer care,” Northwestern University radiation oncologist Laila A. Gharzai, MD, and co-authors wrote May 16 in the Journal of the American College of...